Loading...
Bionomics Limited
BNO.AX•ASX
Healthcare
Biotechnology
A$0.009
A$-0.00(-10.00%)
Bionomics Limited (BNO.AX) Financial Performance & Income Statement Overview
Review Bionomics Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-55866.14%
↓ 55866.14%
Net Income Growth
-48541.02%
↓ 48541.02%
Operating Cash Flow Growth
-3.27%
↓ 3.27%
Operating Margin
-19191.18%
↓ 19191.18%
Gross Margin
-5666.07%
↓ 5666.07%
Net Profit Margin
-16431.03%
↓ 16431.03%
ROE
-89.73%
↓ 89.73%
ROIC
-93.23%
↓ 93.23%
Bionomics Limited (BNO.AX) Income Statement & Financial Overview
Review Bionomics Limited's (BNO.AX) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $98936.00 | $46657.00 |
| Cost of Revenue | $0.00 | $436348.00 | $5.27M | $2.48M |
| Gross Profit | $0.00 | -$436348.00 | -$5.17M | -$2.44M |
| Gross Profit Ratio | $0.00 | $0.00 | -$52.25 | -$52.25 |
| R&D Expenses | $1.90M | $1.11M | $7.73M | $2.48M |
| SG&A Expenses | $1.67M | $131931.00 | $6.16M | $1.98M |
| Operating Expenses | $3.57M | $1.24M | $13.74M | $2.60M |
| Total Costs & Expenses | $3.57M | $1.68M | $10.79M | $5.09M |
| Interest Income | $36096.00 | $14016.00 | $220000.00 | $65686.00 |
| Interest Expense | $0.00 | $0.00 | $10000.00 | $0.00 |
| Depreciation & Amortization | $165713.00 | $436348.00 | $336046.00 | $158475.00 |
| EBITDA | -$3.40M | $400510.00 | -$10.18M | -$4.26M |
| EBITDA Ratio | $0.00 | $0.00 | -$91.27 | -$91.27 |
| Operating Income | -$3.57M | -$1.68M | -$13.74M | -$4.42M |
| Operating Income Ratio | $0.00 | $0.00 | -$138.88 | -$94.66 |
| Other Income/Expenses (Net) | $2.63M | $1.64M | -$182265.00 | -$557308.00 |
| Income Before Tax | -$936974.00 | -$35841.00 | -$15.48M | -$4.97M |
| Income Before Tax Ratio | $0.00 | $0.00 | -$156.46 | -$106.61 |
| Income Tax Expense | -$132187.00 | $45576.00 | -$110000.00 | $34271.00 |
| Net Income | -$804787.00 | -$81418.00 | -$15.37M | -$4.94M |
| Net Income Ratio | $0.00 | $0.00 | -$155.35 | -$105.87 |
| EPS | -$0.05 | $0.00 | -$0.008 | -$0.003 |
| Diluted EPS | -$0.05 | $0.00 | -$0.008 | -$0.003 |
| Weighted Avg Shares Outstanding | $15.60M | $1.86B | $1.92B | $1.95B |
| Weighted Avg Shares Outstanding (Diluted) | $15.60M | $1.86B | $1.92B | $1.95B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan